Cargando…
Ocular Adverse Effects of Gefitinib: A Case Report
Gefitinib is a selective epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor. It is used for treating locally advanced or metastatic non-small cell lung carcinoma and is well tolerated systemically. However, sight-threatening ocular adverse effects, like corneal ulcer and perforation,...
Autores principales: | Jeria, Sandhya, Thool, Archana R, Daigavane, Sachin, Ganjre, Samyak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599912/ https://www.ncbi.nlm.nih.gov/pubmed/36320985 http://dx.doi.org/10.7759/cureus.29600 |
Ejemplares similares
-
Catastrophic ocular complications in leprosy: a case report
por: Ganjre, Samyak Ashok, et al.
Publicado: (2023) -
Confounder for Optic Disc Evaluation in Glaucoma
por: Thool, Archana R, et al.
Publicado: (2023) -
Invasive Acantholytic Ocular Surface Squamous Neoplasia: A Rare Case
por: Sharma, Avi, et al.
Publicado: (2023) -
Ocular Dominance and Its Association With Central Corneal Thickness: An Observational Study in Central India
por: Gundreddy, Ppavani, et al.
Publicado: (2023) -
A Case Report of the Triple Procedure in a Patient - Penetrating Keratoplasty, Extracapsular Cataract Extraction, and Posterior Chamber Intraocular Lens Implantation
por: Rukhiyana, Ronak, et al.
Publicado: (2022)